|Packaging Size||1 Vial|
|Composition||Amphotericin B Emulsion|
|Prescription/ Non prescription||Yes|
|Packaging Size||50 ml|
|Manufactured By||Zydus Ingenia|
Vivitra 440mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).
Vivitra 440mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
|Dosage Form||Powder dosafe form|
|Packaging Size||1 vial|
|Dosage||As per Prescription|
|Country of Origin||Made in India|
It is not known if VENCLEXTA is safe and effective in children.Important Safety InformationWhat is the most important information I should know about VENCLEXTA?
VENCLEXTA can cause serious side effects, including:
Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure, the need for dialysis treatment, and may lead to death. Your healthcare provider will do tests to check your risk of getting TLS before you start taking VENCLEXTA. You will receive other medicines before starting and during treatment with VENCLEXTA to help reduce your risk of TLS.
You may also need to receive intravenous (IV) fluids into your vein. Your healthcare provider will do
blood tests to check for TLS when you first start treatment and during treatment with VENCLEXTA.
It is important to keep your appointments for blood tests. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with VENCLEXTA, including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness,
or muscle or joint pain.
Drink plenty of water during treatment with VENCLEXTA to help reduce your risk of getting TLS. Drink 6 to 8 glasses (about 56 ounces total) of water each day, starting 2 days before your first dose,
on the day of your first dose of VENCLEXTA, and each time your dose is increased.
Your healthcare provider may delay, decrease your dose, or stop treatment with VENCLEXTA if you have side effects. When restarting VENCLEXTA after stopping for 1 week or longer, your healthcare provider may again check for your risk of TLS and change your dose.Who should not take VENCLEXTA?
Certain medicines must not be taken when you first start taking VENCLEXTA and while your dose is being slowly increased because of the risk of increased TLS.
Before taking VENCLEXTA, tell your healthcare provider about all of your medical conditions, including if you:
|Usage/Application||Rheumatoid Arthritis, Ankylosing spondylitis|
|Packaging Size||30 ml vial|
|Drug Strength||450 IU|
|Product Type||Finished Product|
|Minimum Order Quantity||5 Unit|
|Type of Cancer||Breast Cancer|
|Model Name/Number||Acarbrunat 100 mg|
Acabrunat 100mg Capsule is an anticancer medicine containing the active constituent acalabrutinib. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs and the type of lymphocytes affected.
Before taking this medicine, inform your doctor if you have had recent surgery, bleeding problems, heart rhythm problems, infection, are pregnant, or breastfeeding. Acabrunat 100mg Capsule is not recommended for children and adolescents less than 18 years. Use sun protection as this medicine may put you at the risk of developing skin cancer.
Report to your doctor if you develop a lesion or change in the appearance of an area on the skin. Talk to your doctor about all the medications, including herbal medicines, and supplements, before taking Acabrunat 100mg Capsule. Use effective birth control during the treatment and for at least one week after the last dose.
Acabrunat 100mg Capsule uses:
The Acabrunat 100mg Capsule indication are
How Acabrunat 100 mg Capsule works:
It blocks the protein BTK (Bruton tyrosine kinase), which helps these cancer cells grow and survive. By blocking this protein, this medication slows the growth and multiplication of cancer cells.
Interactions with other drugs:
Inform your physician about any medications you are taking or have taken before the treatment.
|Packaging Size||2 x 14|
|Packaging Size||2*28 Capsules|
|Composition||Enzalutamide 40 mg|